Humana Announces Agreement to Divest Minority Interest in Gentiva

Humana has signed a definitive agreement to sell its minority interest in Gentiva, the nation’s largest end-of-life care provider, to a consortium of investors. The transaction values Humana’s stake at approximately $900 million, with proceeds intended for general corporate purposes. The divestiture fulfills Humana’s long-standing strategy to exit non-core hospice and palliative care businesses, originally acquired via Kindred at Home.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.